SpiroGym App-Aided Cough Rehabilitation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-80
SponsorGeneral University Hospital, Prague

About this trial

The pilot study by Srp et al. (2021) proved that the SpiroGym app was feasible for supporting expiratory muscle strength training (EMST) in Parkinson's disease (PD) patients. Two weeks of intensive EMST coupled with SpiroGym were sufficient to significantly improve the participants' voluntary peak cough flow (PCF). The improvement was quantitatively comparable to the results of other intensive EMST studies with longer durations. When interpreting such rapid improvement, the impact of SpiroGym's visual feedback was considered. It was assumed that visual feedback increased training effort compared to regular training without immediate control. However, comparative studies were required to verify the possible additional effects of visual feedback on voluntary PCF compared to EMST without feedback.

Eligibility criteria

Qualifiers

Diagnosis of Parkinsons disease

Stable dopaminergic medication (stable dose for at least 1 month)

Disqualifiers

Other neurological disorders

Difficulty complying due to neuropsychological dysfunction (dementia with a score of less - - than 19 on the Montreal Cognitive Assessment)

Breathing disorders or diseases

Smoking in the past 5 years

Trial design

Treatments tested in this trial

  • Expiratory muscle strength training + SpiroGym application
  • Expiratory muscle strength training

Treatment groups

60 Participants
are divided into 2 treatment groups